Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL
Official Title: A Phase 2, Placebo-controlled, Double-blind, Randomized, Dose Ranging, Efficacy and Safety Study of Orally Administered Moxidectin in Adults With Scabies.
Brief Summary: Moxidectin is not approved to treat scabies in humans.
The effective dose of moxidectin to treat scabies is not known.
This study aims to assess the efficacy of a single administration of 8 mg, 16 mg, or 32 mg moxidectin per oral in achieving Scabies Complete Cure at Day 28.
This study also aims to assess the safety of three strengths of single moxidectin doses in adults with scabies.